Indeed, about two‐thirds of inflammatory cells in NSCLC are lymphocytes, of which 80% are T cells, and lung cancer patients with high levels of infiltrated CD8+ and CD3+ T cells have a better OS.20, 21, 22, 23, 24, 25. This evidence concerns the gene CD8A and lung cancer.